Option chain shows key data for Opthea's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Opthea.

Opthea (NASDAQ:OPT) Stock, Option Chain

OPTHEA LTD-SPON ADR

Opthea

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

Brown & Brown Inc. (NYSE- BRO)

News

Downgrades

Markets

Analyst Ratings

Trading Ideas

AKYA

AZEK

This Brown &amp; Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

bz_pharma_briefs

Biotech

Health Care

General

REGN

Opthea&#39;s Phase 3 COAST trial for wet AMD did not meet its primary endpoint, raising financial concerns as the company faces potential investor obligations.

Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty

Movers

Intraday Update

BELFB

BTBT

EWTX

MBLY

MNSO

MSTR

NVDA

RZLV

TSLA

WULF

XPEV

Darden Restaurants Posts Q1 Results, Joins Tesla, Nvidia, XPeng And Other Big Stocks Moving Higher On Thursday

Opthea Limited - American Depositary Shares

Opthea Ltd

Opus - United States Dollar

ORIENTAL PET & MINERAL B by Oriental Petroleum & Mineral

OPTIMUS GROUP CO LTD. by OPTIMUS GROUP CO LTD.

Optimus Group Co Ltd

OPTIMI HEALTH CORP by OPTIMI HEALTH CORP.

Optimi Health Corp

OPTEC INTERNATIONAL INC by Optec International, Inc.

Optec International Inc

OPTIMUM INTRACTVE USA NEW by Optimum Interactive USA Ltd.

Optimum Interactive USA Ltd

OptiNose Inc

Ocean Power Technologies, Inc. Common Stock

Ocean Power Technologies Inc

Syntec Optics Holdings, Inc. - Class A Common Stock

Syntec Optics Holdings Inc

Optimize Strategy Index ETF

Press Releases

Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference

Opthea Announces Publication in Diabetic Macular Edema

Opthea to Host Investor Days in New York and Australia

Opthea Wet AMD Data Featured at Macula Society Meeting

Opthea to Present at Oppenheimer Healthcare Conference

Opthea Completes COAST Final Week 52 Patient Visit

Opthea Completes Drug Product PPQ Campaign

Earnings

Opthea Reports Half Year Results and Business Updates

Opthea Announces Phase 2b Wet AMD Publication

Opthea Announces COAST Phase 3 Trial Topline Results

AbbVie

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals

Amgen

argenx

Ascendis Pharma A/S - American Depositary Shares

Ascendis Pharma

Biogen

BioMarin Pharmaceutical Inc. - Common Stock

Biomarin Pharmaceutical

BioNTech

Exact Sciences Corporation - Common Stock

Exact Sciences

Exelixis

Gilead Sciences

Genmab

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics

Incyte

Insmed

Madrigal Pharmaceuticals, Inc. - Common Stock

Madrigal Pharmaceuticals

Moderna

Neurocrine Biosciences, Inc. - Common Stock

Neurocrine Biosciences

Natera

BeiGene, Ltd. - American Depositary Shares

BeiGene

Vaxcyte

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals

Roivant Sciences

Summit Therapeutics

United Therapeutics Corporation - Common Stock

United Therapeutics

Vertex Pharmaceuticals Incorporated - Common Stock

Comments

Opthea

Opthea (OPT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga